IQVIA Reports Q2 Non-GAAP EPS of $3.15 and Beats Revenue Estimates

IQVIA (NYSE: IQV) reported second-quarter results that exceeded expectations, with a non-GAAP earnings per share (EPS) of $3.15, beating estimates by $0.12. The company also posted revenue of $4.37 billion for the quarter, surpassing forecasts by $70 million and marking an 8.7% year-over-year increase. The growth was driven by both segments: Commercial Solutions Revenue reached $1.793 billion, up 8.6% from a year ago, while R&D Solutions Revenue hit $2.575 billion, rising 8.8%. The results reflect strong performance across IQVIA's core business areas and suggest continued momentum in the healthcare services sector. The positive earnings surprise is likely to bolster investor confidence in IQVIA’s operational efficiency and market position.

By Deepa Sarvaiya, SA News Editor · Seeking Alpha ·

IQVIA Reports Q2 Non-GAAP EPS of $3.15 and Beats Revenue Estimates

Tickers: $IQV

Topics: earnings pharmaceutical services revenue growth

Read the full article at Seeking Alpha

More World news